EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
News image
News image
On Air
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageWednesday, March 3, 1999 Published at 05:56 GMT
News image
News image
Health
News image
Two-in-one drug could save thousands
News image
Aspirin can help angina sufferers
News image
A new drug that combines aspirin and a nitrate-based drug may provide extra protection for thousands of angina sufferers.

The drug IMAZIN XL is being launched in the week that aspirin celebrates its 100th birthday.

Manufacturers Napp Pharmaceuticals says about one half of the UK's two million angina sufferers do not take aspirin, although it says the drug could save thousands of lives.

The standard treatment for angina, a crushing pain felt in the chest, is drugs containing isosorbide mononitrate.

These help lower blood pressure and prevent angina attacks.

But many people taking isosorbide mononitrates do not take aspirin, which prevents blood clotting.

Fewer drugs to pop

By combining aspirin and isosorbide mononitrate, IMAZIN XL ensures patients will receive both drugs and have fewer pills to pop.

Dr Paul Stillman, a GP from Crawley, said: "IMAZIN XL helps prevent angina and offers long-term protection against heart attack. This new formulation benefits doctors, patients and the NHS."

However, the drug does cause temporary side effects in some patients, including low blood pressure and headaches.

Cambridge-based Napp Pharmaceuticals says it should also not be taken by people with acute angina or kidney and liver failure.

Many studies have shown that aspirin substantially reduces the risk of death or non-fatal heart attacks in patients with a previous MI or unstable angina pectoris, which often occurs before a heart attack.

The Antiplateletes Trialists' Collaboration, which reviewed 145 studies on the role of aspirin in preventing heart attack and stroke, found the drug reduced the risk of non-fatal heart attack by a third.

But there are concerns that aspirin could cause internal bleeding and ulcers if taken in too high doses.

A small number of people are hypersensitive to the drug and cannot tolerate even small amounts.

In higher doses aspirin can cause nausea, heartburn and stomach pain. In a small number of people it can cause cerebral haemorrhage.

Heart attack risk

According to medical statistics, one angina sufferer in 10 will suffer a heart attack within a year of being diagnosed with angina.

Angina, which is more common in men than women, is caused by a decrease in blood supply to the heart.

This is usually the result of a narrowing of the coronary arteries, due to smoking, being overweight, high blood pressure, too much cholesterol, a family history of heart disease or being unfit.

Besides aspirin and nitrate-based drugs, angina can be treated with beta-blockers which slow down the heart rate and reduce the need for oxygen.

News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageNews image
Relevant Stories
News image
28 Feb 99�|�Health
100 years of aspirin
News image
28 Jan 99�|�Health
Brain cancer pill breakthrough
News image

News image
News image
News image
News imageInternet Links
News image
News imageNews image
Napp Pharmaceutical
News image
British Heart Foundation
News image
Aspirin and coronary heart disease
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image